Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 70748-340

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 70748-340). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin Hydrochloride (1a930cb7 5363 4229 9f39 53edc07a43d6 01)

FDA Label Image

Mpeg-dspe (1a930cb7 5363 4229 9f39 53edc07a43d6 02)

FDA Label Image

Hspc (1a930cb7 5363 4229 9f39 53edc07a43d6 03)

FDA Label Image

Pegylated Liposome (1a930cb7 5363 4229 9f39 53edc07a43d6 04)

FDA Label Image

Figure 1 (1a930cb7 5363 4229 9f39 53edc07a43d6 05)

FDA Label Image

Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 06)

This text appears to be a description of a medication called DOXOrubicin Hydrochloride Liposome Injection. It provides information on the recommended dosage, preparation instructions, and intended use for treating infections when diluting the medication. The formulation is specified as a liposomal formulation. The text also mentions a single-dose vial containing 20mg/10mL. It emphasizes that this is a substitute for DOXOrubicin Hydrochloride, indicating its use for specific medical conditions.*

FDA Label Image

Carton Label (1a930cb7 5363 4229 9f39 53edc07a43d6 07)

Description: This document provides detailed information about a medication called DOXOrubicin Hydrochloride Liposome Injection, including its formulation, recommended dosage, and administration instructions. The medication is stored at a specific temperature range and should not be frozen. Additionally, the document includes manufacturing and distribution details for the product.*

FDA Label Image

Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 08)

This is a description of a pharmaceutical product named DOXOrubicin Hydrochloride in Liposome Injection manufactured by Lupin Pharmaceuticals Inc. It contains 50 mg of the active ingredient Doxorubicin in 25 mL solution. The medication is in a liposomal formulation and should not be substituted. The product is meant for intravenous infusion use only and should be discarded if not fully used. It comes in a 25 mL single-dose vial and should not be frozen.*

FDA Label Image

Carton Label (1a930cb7 5363 4229 9f39 53edc07a43d6 09)

This is a product description for Enspatus NIAT, a Liposome Injection of DOXOrubicin Hydrochloride. The product is not a substitute for DOXORBIN Hydrochloride. The recommended dosage is specified for use. The Liposomal formulation comes in a 250 mg vial size. The product is manufactured by Daz Pharma Corporation and distributed by Lupin Pharmaceutical, Inc. It is to be used under proper medical guidance.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.